Stiolto is failing

Several posts above that were NOT me (the OP). Butt hurt boy. It's just you. The rest of us are not ignorant to reality. I've been explain it to you for 2 years now........

 

Dude, ICS is no longer approved for COPD. When you going to learn.

 

Nonsense! ICd/laba is approved in gold guidelines for mostly all categories.

 

Well, been a while but time to check back in. End of July financials are in. 53 Million for Stiolto. SO basically we are a 100 Mil. a year product. After more than 2 years. Fairly pathetic. Spiriva continues to do TWENTY times the sales $$ of Stiolto. Can we finally admit that this product is a dead dog? yore boy will continue to deny it, but it's true. So when will be the final collapse of this flop? When spiriva goes off patent that's when. WIth Spiriva still doing 2B a year it will keep the respiratory dept. going. When Spiriva goes away, we are left with this dog shit product. You don't keep this # of people on staff for a product this pathetic. Our oncology dept. does almost double Stiolto sales and they have 1/5 our sales people. I've been telling you this for 2 years now in order to hopefully give some insight to our future. When spv goes off patent, pack your bags.

 

Read fthe GOLD guidelines under ICS..... Why do you spread the hate?

 

You've been saying that for 2 years now. It hasn't changed SALES. 53 Million through end of July. It's a 100 million dollar drug. It's a flop. It's a joke. Look at your district. If it's like most in the country you've lost most, if not all of your original BI reps. There's a reason for that.

 

Spiriva is doing $2billion a year and the ONLY department it will keep going is the Contract Sales Organization Department so they can continue to work with all their former co-workers at Ashfield filling spots to sell Spriva. All the execs at Ashfield are from BI. This spiriva sales force wasn't hired to "make up for sales from promoting Stiolto" - it was hired to replace all BI respiratory. Clowns. I hope you are all looking for jobs. Astra Zeneca is hiring 2 new sales forces. So is Circassia. Start applying.

QUOTE="anonymous, post: 5914423"]Well, been a while but time to check back in. End of July financials are in. 53 Million for Stiolto. SO basically we are a 100 Mil. a year product. After more than 2 years. Fairly pathetic. Spiriva continues to do TWENTY times the sales $$ of Stiolto. Can we finally admit that this product is a dead dog? yore boy will continue to deny it, but it's true. So when will be the final collapse of this flop? When spiriva goes off patent that's when. WIth Spiriva still doing 2B a year it will keep the respiratory dept. going. When Spiriva goes away, we are left with this dog shit product. You don't keep this # of people on staff for a product this pathetic. Our oncology dept. does almost double Stiolto sales and they have 1/5 our sales people. I've been telling you this for 2 years now in order to hopefully give some insight to our future. When spv goes off patent, pack your bags.[/QUOTE]

 

100% correct. Stiolto was dead @ launch.

[/QUOTE]

 

[/QUOTE]

Former BI respiratory rep here writing in to say how much better it is Selling for the competitor. I am one of the few that was actually polite, respectful and cordial to my accounts and when I did work for BI my day was spent doing damage control. Doctors will always use ICS so stop pissing them off telling them not to. So many of the BI reps do milk calls and it's been doing nothing but making accounts dislike stiolto even more. Now I sell for the competition and my product has better formulary and I do everything the BI reps don't do which is why I succeed. So glad I got out.

 

Former BI respiratory rep here writing in to say how much better it is Selling for the competitor. I am one of the few that was actually polite, respectful and cordial to my accounts and when I did work for BI my day was spent doing damage control. Doctors will always use ICS so stop pissing them off telling them not to. So many of the BI reps do milk calls and it's been doing nothing but making accounts dislike stiolto even more. Now I sell for the competition and my product has better formulary and I do everything the BI reps don't do which is why I succeed. So glad I got out.[/QUOTE]

There's a reason why we have so many former BI reps. Why we have ~ 50% Ashfield reps nationwide, with even more BI reps leaving. That reason is Stiolto. It's a poor product. I've been telling everyone that for 2 years now. It's been - (by a large %) to goal every year. It's flat to declining nationally. The problem is the PRODUCT. Which is what I've been saying for 2 + years now. We needed a triple. No one listened. Now we are forced to live with the end result. The slow, pathetic death of BI respiratory. Very sad actually.

 

How do you build "culture" when >50% of sales force is "8 calls a day" Ashfield. Whose co is this anyway? Tale wag dog.

 

Thank god we have the Purpose & Culture survey. That will deliver us.

 

There's a reason why we have so many former BI reps. Why we have ~ 50% Ashfield reps nationwide, with even more BI reps leaving. That reason is Stiolto. It's a poor product. I've been telling everyone that for 2 years now. It's been - (by a large %) to goal every year. It's flat to declining nationally. The problem is the PRODUCT. Which is what I've been saying for 2 + years now. We needed a triple. No one listened. Now we are forced to live with the end result. The slow, pathetic death of BI respiratory. Very sad actually.[/QUOTE]
Wow reaffirming that my decision to leave this organization is justified.
Truly appreciate all that BIPI gave to advance my career.
Best wishes to all of you who are still holding on

 

Wow reaffirming that my decision to leave this organization is justified.
Truly appreciate all that BIPI gave to advance my career.
Best wishes to all of you who are still holding on[/QUOTE]

You may want to consider medication, or more medication! Get a life!

 

You may want to consider medication, or more medication! Get a life![/QUOTE]

I am not the person in bold. Multiple people feel this way. That's why they've LEFT. You're a silly lemming. It's okay. You can't think for yourself. But that's also why this company is in the very situation it is. No one stood up and said, hey...you know what...this is terrible idea. Yes, be glad you left BI. It's a bad place to be right now. No pipeline. drugs going off patent. Drugs vastly under budget. It's gonna get ugly next year.

 

I would like to thank my Bi DM and nearly entire district for being disliked so much by every HCP in my region. Yes, those long timers who drink the cool-aid, have played into the conquer and divide tactics, have no relationship building skills and for being so arrogant. By doing so destructive, you opened up new opportunities for me b/c they all complained to me and when an opening in a better company surfaced, all the Doctors and offices that like me recommended me. Thank you, BI.

QUOTE="anonymous, post: 5921329"]

You may want to consider medication, or more medication! Get a life![/QUOTE]

I am not the person in bold. Multiple people feel this way. That's why they've LEFT. You're a silly lemming. It's okay. You can't think for yourself. But that's also why this company is in the very situation it is. No one stood up and said, hey...you know what...this is terrible idea. Yes, be glad you left BI. It's a bad place to be right now. No pipeline. drugs going off patent. Drugs vastly under budget. It's gonna get ugly next year.[/QUOTE]

 

Trelegy is approved. Game over. Now what?

 

ive been trying to explain it for 2+ years now. Hope everyone has their resumes fired up. You've got a bit of time til Spiriva goes off patent but then it's game over. This is the reason I started this thread in the first place. If only this company listened and we had developed a triple. Oh well, too late now. Let's sit back and watch another company develop a billion dollar product. Thank goodness we have stiolto to save us. HAHAHAHAH.

 

You are a genius! Wish you were our CEO or POTUS. The world would be a better place.

 

I don't think you realize the fundamental difference with BI. BI rewards reps for having the lowest market share - not just the lowest among our "competition" but the lowest in our company. Look at Presidents club rankings. Those at the top have microscopic market share and have "grown" to earn a trip. It's the reps in large potential areas that might have had a formulary win or more likely asked a physician to put 2 patients on it. This profound growth (sarcasm) has earned them the prestige of being a presidents club winner. What Ever.

For the record, this approval has no impact on anyone. At BI it's about having a higher percentage growth in net sales than any one else. If you have low utilization, it means 1 or 2 "new" docs dabbling in it. Stiolto is not failing. Ask any one with a less than 2% market share. Stiolto is taking them on trips and to the bank!!!

Enjoy your new position and please know that those of here embrace this bizarre business model! Best Wishes!!